UBS Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.38M | Sell |
397,133
-20,488
| -5% | -$226K | ﹤0.01% | 3173 |
|
2025
Q1 | $3.73M | Buy |
417,621
+243,376
| +140% | +$2.17M | ﹤0.01% | 3195 |
|
2024
Q4 | $1.64M | Buy |
174,245
+143,488
| +467% | +$1.35M | ﹤0.01% | 3879 |
|
2024
Q3 | $248K | Sell |
30,757
-3,015
| -9% | -$24.3K | ﹤0.01% | 4542 |
|
2024
Q2 | $286K | Sell |
33,772
-25,317
| -43% | -$215K | ﹤0.01% | 4311 |
|
2024
Q1 | $530K | Sell |
59,089
-11,917
| -17% | -$107K | ﹤0.01% | 4065 |
|
2023
Q4 | $798K | Buy |
71,006
+17,288
| +32% | +$194K | ﹤0.01% | 3599 |
|
2023
Q3 | $464K | Buy |
53,718
+11,007
| +26% | +$95K | ﹤0.01% | 3658 |
|
2023
Q2 | $442K | Buy |
42,711
+15,987
| +60% | +$165K | ﹤0.01% | 3919 |
|
2023
Q1 | $290K | Buy |
26,724
+18,068
| +209% | +$196K | ﹤0.01% | 4090 |
|
2022
Q4 | $97.1K | Buy |
8,656
+8,556
| +8,556% | +$96K | ﹤0.01% | 5009 |
|
2022
Q3 | $1K | Sell |
100
-193
| -66% | -$1.93K | ﹤0.01% | 8930 |
|
2022
Q2 | $2K | Sell |
293
-3,256
| -92% | -$22.2K | ﹤0.01% | 8571 |
|
2022
Q1 | $34K | Buy |
3,549
+1,101
| +45% | +$10.5K | ﹤0.01% | 5850 |
|
2021
Q4 | $27K | Buy |
2,448
+1,683
| +220% | +$18.6K | ﹤0.01% | 6392 |
|
2021
Q3 | $6K | Buy |
765
+665
| +665% | +$5.22K | ﹤0.01% | 7297 |
|
2021
Q2 | $1K | Sell |
100
-218,938
| -100% | -$2.19M | ﹤0.01% | 8077 |
|
2021
Q1 | $4.47M | Buy |
219,038
+50,839
| +30% | +$1.04M | ﹤0.01% | 2067 |
|
2020
Q4 | $2.99M | Buy |
168,199
+85,425
| +103% | +$1.52M | ﹤0.01% | 2279 |
|
2020
Q3 | $1.22M | Buy |
82,774
+80,249
| +3,178% | +$1.19M | ﹤0.01% | 2796 |
|
2020
Q2 | $53K | Sell |
2,525
-1,953
| -44% | -$41K | ﹤0.01% | 4972 |
|
2020
Q1 | $104K | Buy |
4,478
+1,953
| +77% | +$45.4K | ﹤0.01% | 4404 |
|
2019
Q4 | $65K | Sell |
2,525
-197,577
| -99% | -$5.09M | ﹤0.01% | 5171 |
|
2019
Q3 | $3.9M | Buy |
200,102
+192,545
| +2,548% | +$3.75M | ﹤0.01% | 2046 |
|
2019
Q2 | $123K | Buy |
7,557
+2,611
| +53% | +$42.5K | ﹤0.01% | 4413 |
|
2019
Q1 | $112K | Sell |
4,946
-24,546
| -83% | -$556K | ﹤0.01% | 4207 |
|
2018
Q4 | $754K | Buy |
29,492
+23,324
| +378% | +$596K | ﹤0.01% | 3202 |
|
2018
Q3 | $201K | Buy |
6,168
+3,083
| +100% | +$100K | ﹤0.01% | 4230 |
|
2018
Q2 | $70K | Sell |
3,085
-1,426
| -32% | -$32.4K | ﹤0.01% | 4839 |
|
2018
Q1 | $109K | Buy |
4,511
+2,117
| +88% | +$51.2K | ﹤0.01% | 4341 |
|
2017
Q4 | $67K | Sell |
2,394
-4,825
| -67% | -$135K | ﹤0.01% | 4683 |
|
2017
Q3 | $247K | Buy |
7,219
+4,794
| +198% | +$164K | ﹤0.01% | 3881 |
|
2017
Q2 | $96K | Buy |
2,425
+2,225
| +1,113% | +$88.1K | ﹤0.01% | 4312 |
|
2017
Q1 | $7K | Hold |
200
| – | – | ﹤0.01% | 5903 |
|
2016
Q4 | $6K | Sell |
200
-3,083
| -94% | -$92.5K | ﹤0.01% | 6192 |
|
2016
Q3 | $119K | Buy |
3,283
+2,319
| +241% | +$84.1K | ﹤0.01% | 4065 |
|
2016
Q2 | $21K | Sell |
964
-451
| -32% | -$9.83K | ﹤0.01% | 5393 |
|
2016
Q1 | $26K | Sell |
1,415
-4,146
| -75% | -$76.2K | ﹤0.01% | 5193 |
|
2015
Q4 | $91K | Buy |
5,561
+5,061
| +1,012% | +$82.8K | ﹤0.01% | 4298 |
|
2015
Q3 | $6K | Sell |
500
-374
| -43% | -$4.49K | ﹤0.01% | 6203 |
|
2015
Q2 | $12K | Hold |
874
| – | – | ﹤0.01% | 5865 |
|
2015
Q1 | $15K | Sell |
874
-1,931
| -69% | -$33.1K | ﹤0.01% | 5612 |
|
2014
Q4 | $42K | Buy |
+2,805
| New | +$42K | ﹤0.01% | 4872 |
|